133 related articles for article (PubMed ID: 15821444)
1. Triptans induce vasoconstriction of human arteries and veins from the thoracic wall.
Wackenfors A; Jarvius M; Ingemansson R; Edvinsson L; Malmsjö M
J Cardiovasc Pharmacol; 2005 May; 45(5):476-84. PubMed ID: 15821444
[TBL] [Abstract][Full Text] [Related]
2. Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery.
Jähnichen S; Radtke OA; Pertz HH
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):54-63. PubMed ID: 15185063
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the human basilar artery contractile response to 5-HT and triptans.
Silva SA; Marques FB; Fontes Ribeiro CA
Fundam Clin Pharmacol; 2007 Jun; 21(3):265-72. PubMed ID: 17521295
[TBL] [Abstract][Full Text] [Related]
5. Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect.
Edvinsson L; Uddman E; Wackenfors A; Davenport A; Longmore J; Malmsjö M
Clin Sci (Lond); 2005 Sep; 109(3):335-42. PubMed ID: 15853772
[TBL] [Abstract][Full Text] [Related]
6. Vascular effects of 5-HT1B/1D-receptor agonists in patients with migraine headaches.
de Hoon JN; Willigers JM; Troost J; Struijker-Boudier HA; Van Bortel LM
Clin Pharmacol Ther; 2000 Oct; 68(4):418-26. PubMed ID: 11061582
[TBL] [Abstract][Full Text] [Related]
7. 5-HT1D receptor agonists and human coronary artery reactivity in vitro: crossover comparisons of 5-HT and sumatriptan with rizatriptan and L-741,519.
Longmore J; Boulanger CM; Desta B; Hill RG; Schofield WN; Taylor AA
Br J Clin Pharmacol; 1996 Oct; 42(4):431-41. PubMed ID: 8904614
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of action of the 5-HT1B/1D receptor agonists.
Tepper SJ; Rapoport AM; Sheftell FD
Arch Neurol; 2002 Jul; 59(7):1084-8. PubMed ID: 12117355
[TBL] [Abstract][Full Text] [Related]
9. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery.
Longmore J; Maguire JJ; MacLeod A; Street L; Schofield WN; Hill RG
Br J Clin Pharmacol; 2000 Feb; 49(2):126-31. PubMed ID: 10671906
[TBL] [Abstract][Full Text] [Related]
11. Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry.
Nilsson T; Longmore J; Shaw D; Olesen IJ; Edvinsson L
Br J Pharmacol; 1999 Nov; 128(6):1133-40. PubMed ID: 10578124
[TBL] [Abstract][Full Text] [Related]
12. Agonist-directed trafficking explaining the difference between response pattern of naratriptan and sumatriptan in rabbit common carotid artery.
Akin D; Onaran HO; Gurdal H
Br J Pharmacol; 2002 May; 136(2):171-6. PubMed ID: 12010764
[TBL] [Abstract][Full Text] [Related]
13. Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain.
Johnson DE; Rollema H; Schmidt AW; McHarg AD
Eur J Pharmacol; 2001 Aug; 425(3):203-10. PubMed ID: 11513839
[TBL] [Abstract][Full Text] [Related]
14. Current and emerging second-generation triptans in acute migraine therapy: a comparative review.
Deleu D; Hanssens Y
J Clin Pharmacol; 2000 Jul; 40(7):687-700. PubMed ID: 10883409
[TBL] [Abstract][Full Text] [Related]
15. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).
Martin GR; Robertson AD; MacLennan SJ; Prentice DJ; Barrett VJ; Buckingham J; Honey AC; Giles H; Moncada S
Br J Pharmacol; 1997 May; 121(2):157-64. PubMed ID: 9154322
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats.
MacLean MR; Sweeney G; Baird M; McCulloch KM; Houslay M; Morecroft I
Br J Pharmacol; 1996 Nov; 119(5):917-30. PubMed ID: 8922741
[TBL] [Abstract][Full Text] [Related]
17. 5-HT1B-receptors and vascular reactivity in human isolated blood vessels: assessment of the potential craniovascular selectivity of sumatriptan.
Razzaque Z; Pickard JD; Ma QP; Shaw D; Morrison K; Wang T; Longmore J
Br J Clin Pharmacol; 2002 Mar; 53(3):266-74. PubMed ID: 11874390
[TBL] [Abstract][Full Text] [Related]
18. 5-hydroxytryptamine receptors mediating vasoconstriction and vasodilation in perinatal and adult rabbit small pulmonary arteries.
Morecroft I; MacLean MR
Br J Pharmacol; 1998 Sep; 125(1):69-78. PubMed ID: 9776346
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors.
Napier C; Stewart M; Melrose H; Hopkins B; McHarg A; Wallis R
Eur J Pharmacol; 1999 Mar; 368(2-3):259-68. PubMed ID: 10193663
[TBL] [Abstract][Full Text] [Related]
20. Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT(1B) and 5-HT(1D) receptor antagonists and in situ hybridization.
van den Broek RW; Bhalla P; VanDenBrink AM; de Vries R; Sharma HS; Saxena PR
Cephalalgia; 2002 Mar; 22(2):83-93. PubMed ID: 11972574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
